|Bid||2.4500 x 800|
|Ask||2.5000 x 1200|
|Day's range||2.4200 - 2.5400|
|52-week range||0.8600 - 11.0000|
|Beta (5Y monthly)||2.61|
|PE ratio (TTM)||N/A|
|Earnings date||30 Jul 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.00|
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of resTORbio, Inc. (NasdaqGS: TORC) to Adicet Bio, Inc. Under the terms of the proposed transaction, resTORbio will issue a number of shares of resTORbio common stock to Adicet stockholders. Upon closing, shareholders of Adicet will own approximately 75% of the outstanding common stock of resTORbio, while resTORbio shareholders will own only approximately 25%. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...